Scintigraphic Evaluation of Patients with Malignant Tumor of the Head and Neck by Thallium-201-chloride (Tl-201) Scintigraphy  by Sato, Tsuyoshi et al.
Introduction
　Thallium-201-chloride（Tl-201）was first used to 
evaluate the viability of the myocardium, and has since 
been introduced to examine tumor lesions in view of its 
good accumulation in malignant tumors1-6.  Immediate-
ly after its approval in 1994, this scintigraphic agent 
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Abstract : The purpose of this study was to evaluate the usefulness of thallium-201-chloride（Tl-201）scin-
tigraphy for the examination of patients with tumors of the head and neck, and to estimate the correlation of 
the expression of Na＋/K＋-ATPase with Tl-201 scintigraphy.  Tl-201 scintigraphy was performed in 61 patients 
with squamous cell carcinoma and 10 patients with benign tumors of the salivary gland.  The tumor retention 
index was obtained from the early and delayed dynamic Tl-201 scintigraphies.  The expression of Na＋/K＋
-ATPase on the cell membrane was evaluated immunohistochemically.  Evaluation of correlations between the 
histopathological tissue differentiation of tumors, the tumor retention index of Tl-201 scintigraphy and the ex-
pression of Na＋/K＋-ATPase was performed.  The tumor retention index of Tl-201 scintigraphy correlated well 
with the histopathological tissue differentiation of tumors and also showed a good correlation with the expres-
sion of Na＋/K＋-ATPase.  In addition, the expression of Na＋/K＋-ATPase demonstrated a close correlation with 
the histopathological tissue differentiation of malignant tumors.  The tumor retention index could be used for 
the differentiation of malignant tumors from benign tumors and the expression of Na＋/K＋-ATPase was esti-
mated as one of the most important factors for Tl-201 accumulation in malignant tumors.
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was rapidly introduced for the examination of patients 
with malignant tumors of the head and neck.  We have 
used this agent since 1996 and have examined about 
300 cases by Tl-201 scintigraphy.  In our previous re-
port7, we concluded that the Tl-201 accumulation in ma-
lignant tumors was evident in the early phase after the 
intravenous injection of Tl-201 and the accumulation 
remained steady in the late phase（a couple of hours af-
ter the injection）.  Furthermore, the accumulation of 
the late phase sometimes increased rather than that of 
the early phase.  On the other hand, the Tl-201 accumu-
lation of the late phase in benign tumors usually de-
creased, although the accumulation in the early phase 
was as distinct as that in malignant tumors.  This dif-
ference between malignant tumors and benign tumors 
depended on the accumulation mechanism of Tl-2014,5. 
Furthermore, this accumulation mechanism was pre-
sumed to relate closely with the expression of Na＋/K＋
-ATPase on the cell membrane because of Tl＋-ion's 
physical characteristics similar to K＋-ion6.  As for Na＋/
K＋-ATPase, the expression of Na＋/K＋-ATPase was 
strongly observed in high-grade malignant tumors more 
than in low-grade ones.  Na＋/K＋-ATPase produces 
transmembrane concentration gradients for Na＋-ion 
and K＋-ion through the hydrolysis of one molecule of 
ATP2,4,5,8.  However, the mechanism of Tl-201 uptake by 
Na＋/K＋-ATPase is not completely understood9, and 
there have been few reports concerning the relationship 
between the accumulation of Tl-201 and the expression 
of Na＋/K＋-ATPase in malignant tumors of the head and 
neck.
　In the present report, we evaluated the relationship 
between the accumulation of Tl-201 scintigraphy and 
the expression of Na＋/K＋-ATPase to clarify the accumu-
lation mechanism of Tl-201 in malignant tumors of the 
head and neck.
Materials and Methods
1. Patients
　Sixty-one patients of 25 females and 36 males with 
squamous cell carcinoma in the maxilla（3 females and 
8 males）, the mandible（6 females and 9 males）, the 
tongue（9 females and 12 males）, the oral ﬂ oor（3 fe-
males and 5 males）and the buccal mucosa（4 females 
and 2 males）were used in the present study.  More-
over, 10 patients with benign salivary gland tumor of 
pleomorphic adenoma（3 females and 4 males）and 
Warthin's tumor（1 female and 2 males）were also in-
cluded in this study.  These 71 patients were examined 
because of clinically suspected malignant lesions.  Their 
ages ranged from 35 to 88 years old.  Patient distribu-
tion according to diagnosis and gender is shown in Table 
1.  They were examined by Tl-201 scintigraphy and the 
samples of patients with malignant tumor obtained 
from excised tumor tissue were used for the immunohis-
tochemistry of the expression of Na＋/K＋-ATPase.  The 
histopathological diagnosis of tissue differentiation was 
performed by pathologists in the clinical laboratory.  We 
used patients with salivary gland tumors as a benign 
control of the scintigraphy.  These salivary gland tumors 
have a different cell nature from squamous cell carcino-
ma.  However, it is not inadequate to compare the scin-
tigraphic results between the salivary gland tumors and 
squamous cell tumors, because the grade of accumula-
tion of Tl-201 chieﬂ y depends on the cell activity, for ex-
ample, the growth speed of tumors.
2. Scintigraphy
　Tl-201 scintigraphy was performed by using the in-
travenous administration of 74 MBq per 2 mL of Tl-201. 
An early dynamic scan（for 5 minutes immediately af-
ter injection）and delayed dynamic scan（at 2.5 hours 
after injection）were carried out by using a Gamma 
View scintillation camera（Hitachi, Ltd., Tokyo, Japan）
with a low-energy ultra-high-resolution parallel hole 
collimator.  Two-second scans were obtained continuous-
ly for up to 5 minutes.  A single 2-second scan constitut-
ed a frame data.  Two regions of interest（ROI）on each 
frame, covering both the tumor area（Fig. 1, A）and 
the contralaterally symmetrical region（control region, 
Fig. 1, B）, were used to evaluate the uptake of Tl-201 in 
tumor（time activity curve, Fig. 2）.  The early and de-
layed retention indexes of the tumor were calculated 
from the results of each dynamic scan.  The early reten-
tion index was the count of tumor divided by the count 
of control in the early dynamic scan（from 4 to 5 min-
Table 1　Patient for T1-201 scintigraphy and Na＋/K＋-
ATPase expression
Diagnosis female male
Squamous cell carcinoma 25 36
Benign tumor of salivary gland  4  6
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utes after injection）.  The delayed retention index was 
the count of tumor divided by the count of control in the 
delayed dynamic scan（for 2 minutes at 2.5 hours after 
injection）.  Then, the ratio of the delayed retention in-
dex to the early retention index was calculated as the 
tumor retention index.  These retention indexes were 
obtained with reference to reports in the literature.7,10
3. Immunohistochemistry
　Immunohistochemical staining was performed with 
histopathological samples taken from patients.  Brieﬂ y, 
10% formalin-ﬁ xed parafﬁ n embedded sections（5μm）
of the resected tumor were mounted on adherent glass 
slides（Matsunami Glass Ind. Ltd., Japan）.  Sections 
were deparafﬁ nized in Hemo-clear（S & S Company of 
Georgia Inc., U.S.A.）and rehydrated in graded etha-
nols.  Slides were treated with 0.1-mol/L sodium citrate 
buffer（pH 6）, heated in an autoclave at 121℃ for 10 
minutes for the antigen retrieval, and then treated with 
2% hydrogen peroxide for 10 minutes to block endoge-
nous peroxidase activity.  Sections were incubated 
with the primary monoclonal antibody（anti-mouse 
Mab Na＋/K＋-ATPase α, M7-PB-E9, Affinity Bio. Inc., 
U.S.A.）in a moist chamber at room temperature over-
night, and then incubated with secondary monoclonal 
antibody（Biotinized anti-IgG Ab, Affinity Bio. Inc., 
U.S.A.）for 30 minutes at room temperature.  After in-
cubation, the sections were washed with TBS（Tris-buf-
fer Saline, DAKO, U.S.A.）, reacted with ABC（Avidin-
Biotinylated-Peroxidase Complex, Vector Lab. Inc., 
U.S.A.）, and stained with DAB（Diaminobenzidine, 
Dojindo Lab., WAKO, Japan）11, 12.  The sections were 
lightly counterstained with hematoxylin and cover-
slipped.  The negative control consisted of omission of 
the primary monoclonal antibody using a case of squa-
mous cell carcinoma, and the positive control was ob-
tained using a section of the kidney because Na＋/K＋
-ATPase distributes physiologically and abundantly on 
their cell membranes13.  Na＋/K＋-ATPase expression of 
the immunohistochemistry was graded visually on the 
photomicroscopy into score-0（stained under 5%）, 
score-1（from 5 to 49%）, or score-2（over 50%）8,12  with 
reference to the negative（Fig. 3, A）and positive（Fig. 
3, B）controls.
4. Statistical evaluation
　A chi-square test was performed for the statistical 
evaluation of the correlation between the histopatholog-
ical tissue, the tumor retention index of Tl-201 scintig-
raphy and the expression of Na＋/K＋-ATPase.
Fig. 1　Two regions of interest（ROI）on a 2-second 
frame image covering the tumor area（A）and 
the contralaterally symmetrical region（B, control 
region）.
Fig. 2　Time activity curve. The early and delayed reten-
tion indexes of the tumor were calculated from 
the radioactive count shown by the two curves. 
The early retention index was the count of tumor / 
the count of control in the early dynamic curves
（from 4 to 5 minutes after injection）. The delayed 
retention index was the count of tumor / the count 
of control in the delayed dynamic curves（for 2 
minutes at 2.5 hours after injection）. The ratio of 
the delayed retention index to the early retention 
index was calculated as the tumor retention in-
dex.
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Results
1. Distribution of tumor retention index of Tl-201 
scintigraphy
　Tumor retention indexes of 71 patients with benign 
and malignant tumors were distributed as shown in 
Fig. 4.  In patients with benign tumor, the tumor reten-
tion indexes ranged from 0.75 to 0.93 with the average
± SD of 0.810± 0.0613.  In patients with malignant 
tumor, the tumor retention indexes ranged from 0.78 to 
Fig. 3　Immunohistochemical staining of Na＋/K＋-ATPase. Negative 
control（A）consists of omission of the primary monoclonal 
antibody and the positive control（B）is obtained using the 
section of the kidney because Na＋/K＋-ATPase showed a 
physical and distinct distribution on its cell membrane.
Fig. 4　Distribution of tumor retention indexes of 71 patients with benign 
and malignant tumors. In patients with benign tumor, the tumor 
retention indexes ranged from 0.75 to 0.93.  In patients with malig-
nant tumor, the tumor retention indexes ranged from 0.78 to 1.29 
in the well-differentiated group, from 0.80 to 1.42 in the moderate-
ly differentiated group, and from 0.98 to 1.46 in the poorly differen-
tiated group.
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1.29 in the well-differentiated group with the average
± SD of 0.962± 0.144, from 0.80 to 1.42 in the moder-
ately differentiated group with the average±SD of 1.00
± 0.127, and from 0.98 to 1.46 in the poorly differenti-
ated group with the average± SD of 1.18± 0.140.
　From the results, the tumor retention indexes were 
classiﬁ ed into three groups with reference to our previ-
ous report7:  decreased（＜ 0.9）, unchanged（0.9-1.1）
and increased（1.1＜）in Table 2.  Most patients（8/10 
patients, 80%）in benign tumors belonged to the de-
creased group.  On the other hand, most patients of the 
well-, moderately and poorly differentiated groups in 
malignant tumors were found in the decreased group
（15/28 patients, 54%）, the unchanged group（16/27 pa-
tients, 60%）and the increased group（5/6 patients, 
83%）respectively.  Thus, most patients of the poorly 
differentiated group belonged to the increased group of 
the tumor retention index, although most patients with 
benign tumor and most patients of the well-differentiat-
ed group were found in the decreased group of the re-
tention index.  A statistical analysis with the chi-square 
test was carried out.  The results indicated a signiﬁ cant 
correlation between the tumor retention index and the 
histopathological tissue differentiation（p＝0.001）.
2. Histopathological tissue differentiation of ma-
lignant tumor and Na＋/K＋-ATPase expression
　This evaluation was carried out in patients with ma-
Table 2　Tumor retention index and tissue differentiation
Tumor retention index＊，＊＊
Decreased
＜ 0.9
Unchanged
0.9-1.1
Increased
1.1＜
Benign tumor  8（80%）  2（20%）  0（ 0%）
Malignant tumor
（Tissue differentiation）
Well 15（54%）  7（25%）  6（21%）
Moderately  5（19%） 16（60%）  6（22%）
Poorly  0（ 0%）  1（17%）  5（83%）
　＊with benign tumor : chi-square＝ 28.53＞ 22.458（p＝0.001）
＊＊without benign tumor : chi-square＝ 19.66＞ 18.468（p＝0.001）
Table 3　Tissue differentiation and Na＋/K＋-ATPase expression
Na＋/K＋-ATPase expression＊
Score-0 Score-1 Score-2
Tissue differentiation
Well 10（36%） 13（46%）  5（18%）
Moderately  0（ 0%） 15（56%） 12（44%）
Poorly  1（16.6%）  1（16.6%）  4（66.6%）
＊ chi-square＝ 16.17＞ 14.86（p＝0.005）
Table 4　Tumor retention index and Na＋/K＋-ATPase expression
Na＋/K＋-ATPase expression＊
Score-0 Score-1 Score-2
Tumor retention index
Decreased  8（40%）  9（45%）  3（15%）
Unchanged  1（ 4%） 14（58%）  9（38%）
Increased  2（12%）  6（35%）  9（53%）
＊ chi-square＝ 13.39＞ 13.277（p＝0.01）
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lignant tumor（Table 3）.  Scores-0, 1 and 2 were evalu-
ated with reference to the controls on the photomicros-
copy.  In the well- or moderately differentiated group（55 
patients）, most patients（38/55 patients, 69%）had a 
tendency to show score-0 or score-1.  However, most pa-
tients of the poorly differentiated group belonged to the 
score-2 group（4/6 patients, 66.6%）.  The frequency of 
score-2 distinctly increased with higher grade of histo-
pathological tissue differentiation.  There was a statisti-
cal correlation between the histopathological tissue dif-
ferentiation of malignant tumor and Na＋/K＋-ATPase 
expression（p＝0.005）.
3. Tumor retention index of Tl-201 scintigraphy 
and Na＋/K＋-ATPase expression in patients with 
malignant tumor
　This evaluation was performed in patients with ma-
lignant tumor（Table 4）.  In the decreased or un-
Fig. 5　Case 1 : Patient with pleomorphic adenoma in the lower part 
of the left parotid gland. Early spot image of Tl-201 scintig-
raphy showed a warm uptake（A, arrow）. However, the up-
take completely disappeared in the delayed image（B）.
Fig. 6　The time activity curves of case 1 demonstrated the 
change of difference of radioactive count between the
tumor and the control from the early phase（A ; tumor, 
arrow ; control, arrowhead）to the delayed phase（B）.
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changed tumor retention index group（44 patients）, 
most patients were included in the score-0 or score-1 
group（32/44 patients, 73%）.  On the other hand, most 
patients of the increased tumor retention index group 
showed score-2（9/17 patients, 53%）.  Thus, the fre-
quency of score-2 increased with larger tumor retention 
index.  There was a statistical correlation between the 
tumor retention index of Tl-201 scintigraphy and Na＋/
K＋-ATPase expression（p＝0.01）.
4. Case presentation
　Case 1 : Patient with benign salivary gland tumor of 
pleomorphic adenoma in the lower part of the left parot-
id gland.  Early spot image of Tl-201 scintigraphy 
showed a warm uptake（Fig. 5, A, arrow）.  However, 
the uptake completely disappeared in the delayed image
（Fig. 5, B）.  The time activity curves in Fig. 6 demon-
strate the change of difference of radioactive count be-
tween the tumor and the control from the early phase
（Fig. 6, A, tumor ; arrow, control ; arrowhead）to the de-
layed phase（Fig. 6, B）. 
　Case 2 : Patient with squamous cell carcinoma of the 
left oral ﬂ oor.  Tl-201 scintigraphy showed a marked ac-
cumulation of the tumor in the early spot image（Fig. 7, 
A, arrow）.  The accumulation in the delayed spot image
（Fig. 7, B）did not show any decrease or was rather 
distinct compared to that in the early spot image.  The 
tumor retention index of Tl-201 scintigraphy was 1.17
（belongs to the increased tumor retention index group）. 
The expression of Na＋/K＋-ATPase was clear on the cell 
membrane and estimated as score-2（Fig. 8）.
Discussion
　We showed the usefulness of Tl-201 scintigraphy in 
our previous report7.  We also indicated that the tumor 
retention index of Tl-201 scintigraphy provided supple-
Fig. 7　Case 2 : Patient with squamous cell carcinoma of the left oral 
ﬂ oor. Tl-201 scintigraphy showed a marked accumulation of the 
tumor in the early spot image（A, arrow）. The accumulation in 
the delayed spot image（B）did not show any decrease or was 
rather more distinct than that in the early spot image（A）.
Fig. 8　The expression of Na＋/K＋-ATPase of case 2 was 
clear on the cell membrane and estimated as 
score-2.
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mentary but important information to predict the grade 
of histopathological tissue differentiation.  Some previ-
ous reports14-16 demonstrated almost the same results 
as ours that the tumor retention index of Tl-201 scintig-
raphy was useful to differentiate benign tumors from 
malignant tumors, and it was closely related to the 
grade of histopathological tissue differentiation.  Saijo 
and co-workers17 reported that the prognosis of pa-
tients with adenocarcinoma was better among patients 
with well-differentiated tumor than those with poorly 
differentiated tumor.  Therefore, this tumor retention 
index of Tl-201 scintigraphy could be a supplementary 
factor to predict the prognosis of patients.  In the pres-
ent report, we evaluated the usefulness of the tumor re-
tention index of Tl-201 scintigraphy with 71 patients 
including 61 patients with malignant tumor and 10 pa-
tients with benign tumor.  The tumor retention index of 
Tl-201 scintigraphy of the present study showed a good 
correlation with the histopathological tissue differentia-
tion of tumors.  The tumor retention index of Tl-201 
scintigraphy tended to be larger in malignant tumors 
than in benign lesions, and furthermore, the tumor re-
tention index became large with higher grade of histo-
pathological differentiation7,14-16.  Thus, we think that 
the tumor retention index is one of the important meth-
ods to predict the prognosis of patients with malignant 
tumors of the head and neck.  As for the accumulation 
mechanism of Tl-2014-6, there are two steps : in the ﬁ rst 
step the intravenously injected Tl-201 accumulates 
around tumor cells from the injected site, and in the 
second step Tl-201 goes through the cell membrane18,19. 
The injected Tl-201 flows and reaches the tumor cells 
through the tumor vascular system.  Tl-201 accumula-
tion of the first step mainly depends on the volume of 
blood ﬂ ow and blood pool7.  Because the volume of blood 
ﬂ ow is generally rich in malignant tumors20 and the tu-
mor vascular system has many fenestrae leading to 
high permeability, Tl-201 easily moves to tumor cells. 
Also due to the decrease in blood ﬂ ow in malignant tu-
mors, Tl-201 accumulates in tumor cells21,  as a result of 
which, a lot of Tl-201 accumulates around tumor cells. 
There are some factors concerning Tl-201 transporta-
tion inside tumor cells.  Tl-201 has physical characteris-
tics similar to potassium because of its ion-radius being 
similar to potassium7.  Tl-201 is a potassium analog and 
has ﬁ ve times the afﬁ nity to cell as potassium8.  As for 
the role of Na＋/K＋-ATPase in the transportation of 
Tl-201 into tumor cells, Na＋/K＋-ATPase is distributed 
widely in malignant tumor cells22-25 and probably plays 
one of the most important roles6,11-13.  In the present 
study, Na＋/K＋-ATPase expression in patients with 
squamous cell carcinoma was classified into three 
grades of scores-0, 1, and 2 immunohistochemically. 
Most patients of the well-differentiated group showed 
score-0（36%）and score-1（46%）.  Score-2 was shown 
in only 18% of patients.  In contrast, patients of the 
poorly differentiated group showed score-2 in 4/6 pa-
tients（66.6%）and score-0 in only 1/6 patients（16.6%）. 
Thus, Na＋/K＋-ATPase expression closely was related to 
the grade of histopathological tissue differentiation of 
tumors.  Furthermore, patients revealed almost the 
same results between the tumor retention index and the 
expression of Na＋/K＋-ATPase23.  Patients showed an 
obvious difference among the three tumor retention in-
dex groups concerning the expression of Na＋/K＋-
ATPase.  Score-2 was observed in 15%, 38% and 53% of 
patients of the decreased, unchanged and increased tu-
mor retention index groups.  Based on these results, 
there was no doubt that the expression of Na＋/K＋-
ATPase was higher in the high-grade malignant tumors 
than the low-grade malignant tumors and that Na＋/K＋-
ATPase played one of the most important roles in Tl-201 
transportation into tumor cells.  This speculation was 
supported by an in-vitro experiment that the active 
transport of Tl-201 into malignant tumor cells was reg-
ulated by Na＋/K＋-ATPase20,21.  However, the expression 
of Na＋/K＋-ATPase showed a difference between the his-
topathological tissue differentiation and the tumor re-
tention index.  It had a higher correlation with the his-
topathological tissue differentiation than the tumor 
retention index of Tl-201 scintigraphy.  This difference 
probably arises because the tumor retention index was 
affected remarkably by the tumor vascular system, for 
example, the volume of blood flow, the blood pool, the 
amount of tumor vessels, and the vascular permeability. 
We reported in our previous report7 that the tumor re-
tention index revealed a good correlation with the tu-
mor vascular system.  Thus, the tumor vascular system 
also plays an important role in the Tl-201 scintigraphy 
the same as the expression of Na＋/K＋-ATPase.
　In conclusion, the transportation of Tl-201 into tumor 
cells would depend on the expression of Na＋/K＋-
ATPase.  The tumor retention index of Tl-201 scintigra-
phy can thus be used as an adjunct in predicting the 
16 Oral Science International　Vol. 2, No. 1
histopathological tissue differentiation of tumors of the 
head and neck.
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